On another kidney cancer board there was info on a new treatment whose results are so good in Phase III they have stopped the trial and are going for approval.All of the patients onthe trial had advanced kidney cancer that did not respond to Stuten, Nexavar, and Torisel. Not sure what it entails but I would write to the company and see if there is any was to volunarily take it . It is called Everolimus, or RAD001 and is made by Novartis. Google Everolimus and you should find it. Says they had significant results with advance RCC. here is the message and the link to the article:
For those like me who have a time of keeping all this straight Everolimus is aka RAD-001
Everolimus is approved under the trade-name Certican® for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003 and is available in more than 60 countries.
More:
http://tinyurl.com/342sao
Best,
Bill Bro, CEO, www.kidneycancer.org